{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:01:29Z","timestamp":1791806489261,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T00:00:00Z","timestamp":1429488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jhep.2015.04.013","type":"journal-article","created":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T02:29:30Z","timestamp":1429583370000},"page":"670-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation"],"prefix":"10.1016","volume":"63","author":[{"given":"Cristina","family":"B\u00e1rcena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tutusaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Joannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anghara","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Sancho-Bru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Mar\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Caballeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla V.","family":"Rothlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Fern\u00e1ndez-Checa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Garc\u00eda","family":"de Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2015.04.013_b0005","doi-asserted-by":"crossref","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","article-title":"Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis","volume":"305","author":"Mallat","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jhep.2015.04.013_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2015.04.013_b0015","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","article-title":"Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma","volume":"72","author":"Coulouarn","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2015.04.013_b0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2015.04.013_b0025","doi-asserted-by":"crossref","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jhep.2015.04.013_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-2001-17558","article-title":"Hepatic stellate cells as a target for the treatment of liver fibrosis","volume":"21","author":"Bataller","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2015.04.013_b0035","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2015.04.013_b0040","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1053\/j.gastro.2012.06.036","article-title":"Deactivation of hepatic stellate cells during liver fibrosis resolution in mice","volume":"143","author":"Troeger","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.04.013_b0045","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.04.013_b0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nri2303","article-title":"Immunobiology of the TAM receptors","volume":"8","author":"Lemke","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2015.04.013_b0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jhep.2015.04.013_b0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0083-6729(07)00009-X","article-title":"Vitamin K-dependent actions of Gas6","volume":"78","author":"Bellido-Martin","year":"2008","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jhep.2015.04.013_b0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1160\/TH08-04-0253","article-title":"Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation","volume":"100","author":"Fernandez-Fernandez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2015.04.013_b0070","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.23833","article-title":"Growth arrest-specific protein 6 is hepatoprotective against murine ischemia\/reperfusion injury","volume":"52","author":"Llacuna","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.013_b0075","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1053\/j.gastro.2005.08.004","article-title":"Expression and role of Gas6 protein and of its receptor Axl in hepatic regeneration from oval cells in the rat","volume":"129","author":"Couchie","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2015.04.013_b0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2009.02.030","article-title":"Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice","volume":"51","author":"Lafdil","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2015.04.013_b0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/hep.21237","article-title":"Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells","volume":"44","author":"Lafdil","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.013_b0090","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1158\/0008-5472.CAN-09-2997","article-title":"R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer","volume":"70","author":"Holland","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2015.04.013_b0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nbt0913-775a","article-title":"First Axl inhibitor enters clinical trials","volume":"31","author":"Sheridan","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2015.04.013_b0100","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1074\/jbc.M111.272393","article-title":"Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease","volume":"287","author":"Moles","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2015.04.013_b0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.24388","article-title":"Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis","volume":"54","author":"Tarrats","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2015.04.013_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2015.04.013_b0115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2353\/ajpath.2010.091257","article-title":"Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis","volume":"177","author":"Moles","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2015.04.013_b0120","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/ar4199","article-title":"Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity","volume":"15","author":"Recarte-Pelz","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2015.04.013_b0125","doi-asserted-by":"crossref","first-page":"G1043","DOI":"10.1152\/ajpgi.00311.2010","article-title":"Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice","volume":"300","author":"Fourcot","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2015.04.013_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/path.2381","article-title":"Genetic loss of Gas6 induces plaque stability in experimental atherosclerosis","volume":"216","author":"Lutgens","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.jhep.2015.04.013_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijcard.2014.03.016","article-title":"AXL receptor tyrosine kinase is increased in patients with heart failure","volume":"173","author":"Batlle","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jhep.2015.04.013_b0140","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/cc9233","article-title":"Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes","volume":"14","author":"Ekman","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jhep.2015.04.013_b0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2011.134","article-title":"Alcoholic liver disease: pathogenesis and new targets for therapy","volume":"8","author":"Altamirano","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2015.04.013_b0150","series-title":"BGB324, a selective small molecule Axl kinase inhibitor to overcome EMT-associated drug resistance in carcinomas: Therapeutic rationale and early clinical studies","author":"Wnuk-Lipinska","year":"2014"},{"key":"10.1016\/j.jhep.2015.04.013_b0155","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1158\/1535-7163.MCT-13-1083","article-title":"Axl kinase as a key target for oncology: focus on small molecule inhibitors","volume":"13","author":"Feneyrolles","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2015.04.013_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-07-0862","article-title":"Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme","volume":"14","author":"Hutterer","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2015.04.013_b0165","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2013-03-491431","article-title":"Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma","volume":"122","author":"Ben-Batalla","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2015.04.013_b0170","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.0909333107","article-title":"Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival","volume":"107","author":"Gjerdrum","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.04.013_b0175","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2013.05.019","article-title":"Gas6\/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients","volume":"435","author":"Han","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2015.04.013_b0180","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/1078-0432.CCR-08-2514","article-title":"Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival","volume":"15","author":"Gustafsson","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2015.04.013_b0185","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ng.2330","article-title":"Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2015.04.013_b0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.immuni.2013.06.010","article-title":"T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response","volume":"39","author":"Carrera Silva","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2015.04.013_b0195","doi-asserted-by":"crossref","first-page":"13091","DOI":"10.1073\/pnas.1302507110","article-title":"Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer","volume":"110","author":"Bosurgi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2015.04.013_b0200","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nchembio.1636","article-title":"An engineered Axl \u2018decoy receptor\u2019 effectively silences the Gas6-Axl signaling axis","volume":"10","author":"Kariolis","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jhep.2015.04.013_b0205","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4236\/jct.2013.42079","volume":"4","author":"Uehara","year":"2013","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.jhep.2015.04.013_b0210","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J Clin Invest"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827815002962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T21:17:05Z","timestamp":1566595025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827815002962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0168827815002962"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2015.04.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gas6\/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2015.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}